Therapeutic Efficacy of Linezolid and Rifampicin
against Experimentally Induced MRSA Mediastinitis in Rabbits
Muhammad Nadeem Asi*, Ghulam Muhammad, Farah
Deeba and Faqir Muhammad1
Department of Clinical Medicine and Surgery; 1Department
of Physiology and Pharmacology, University of Agriculture,
Faisalabad-38040, Pakistan;
*Corresponding author:
mnadeemasi@gmail.com
Abstract
Methicillin-resistant
Staphylococcus aureus (MRSA) remains a significant challenge for
human and veterinary health professions especially in the developing nations.
Resistance to wide array of antibiotics is a major hurdle in treating MRSA
infections including mediastinitis. In present study, therapeutic efficacy of
linezolid alone and in combination with rifampicin was evaluated in
experimentally induced MRSA mediastinitis in rabbits. Experimental upper median
sternotomy was performed on 56 rabbits divided into seven groups. Out of these
seven groups, one was taken as uncontaminated control group; one as untreated
contaminated group; two groups were given different doses of linezolid, one
group was treated with rifampicin alone whereas remaining two groups were given
combinational therapy of linezolid and rifampicin. Both 50 mg/kg and 100 mg/kg
dose rates of linezolid were found to be effective whereas no added benefit was
observed in rabbits given a combination of rifampicin and linezolid. Linezolid
can be used in serious MRSA infections especially in those patients not
responding to conventional antimicrobial therapy but the selection of correct
dose of linezolid is important in each patient.